Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharmaceutical Executive, October 2022 Issue (PDF)
Articles in this issue
2022 Pharmaceutical Executive APEX Awards Program
Healthy Planet, Healthy People: How Pharma Can Lead the Way
At the Heart of Pharma: ESG has Arrived as a Central Strategy
Discerning Dealmaking: Caution Flag Still Raised in Biopharma M&A Race
Keeping it Simple
All About the Rates: The Fallout of Fed Hikes for Biotech
Exploring Fixed and Variable Coverage Principles
Inclusion Check-In: Who are You Giving Your Energy To?
Cracking the Code to Commercial Promise in Asia
Push for Full Embrace of Digital Care Draws Opposition in Europe
Seeking Harmonized Testing, Regulation, and Manufacturing
R&D’s Financial Focus
Pharmaceutical Executive, October 2022 Issue (PDF)
Elevating ESG Message: Today’s Modern Investor is Key
Recent Videos
Related Content
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Podcast
Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
